Feature
Top stories of 2021: Part four
A combination of freedoms, lockdowns, surging cases, mask rules, a complicated vaccine rollout, and more has made it an eventful year for GPs.
COVID-19 vaccines unsurprisingly dominated much of the general practice news cycle in 2021.
As the COVID vaccine rollout ramped up, people throughout Australia sought information on the country’s two primary options: AstraZeneca and Pfizer.
As the year draws to a close, newsGP counts down the 10 most-read stories for 2021.
Today it’s the year’s two most popular.
2
Evidence suggests AstraZeneca and Pfizer are equally effective
(Published 11 May)
Experts say the research is reassuring and indicates that both COVID vaccines offer a pathway to Australia reaching a high level of immunity.
1
AstraZeneca and Pfizer: What are the side effects of Australia’s vaccines?
(Published 3 May)
People under 55, women and those previously infected with COVID-19 are more likely to report side effects after receiving either vaccine, according to new research.
Log in below to join the conversation.
AstraZeneca Pfizer top stories vaccine rollout
newsGP weekly poll
Is it becoming more difficult to access specialist psychiatric support for patients with complex mental presentations?